Literature DB >> 25315741

Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.

Shuxiang Pu1, Youming Long, Ning Yang, Yihua He, Fulan Shan, Yongxiang Fan, Jianrui Yin, Qingchun Gao, Gao Cong.   

Abstract

The objective of this study was to analyze the frequency of syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with positive aquaporin-4 (AQP4) antibodies and evaluate the relationship between SIADH and hypothalamic lesions in patients with NMO and NMO spectrum disorder (NMOSD). AQP4 antibodies were tested by an indirect immunofluorescence assay employing HEK-293 cells transfected with recombinant human AQP4. Clinical data of patients were analyzed retrospectively. In total, 192 patients with AQP4 antibodies were certified, of which 41 patients (21.4 %) were included in the present study. Six patients (14.6 %, 6/41) met the criteria of SIADH, of which hyponatremia was mild in one patient, and severe in five. Five patients experienced confusion or decreased consciousness. Four patients were diagnosed with NMO and two were diagnosed with recurrent optic neuritis. Magnetic resonance imaging showed 11 of 41 patients (26.8 %) had hypothalamic lesions. All patients with SIADH had hypothalamic abnormalities. Hyponatremia resolved in all patients after intravenous methylprednisolone and intravenous immunoglobulin therapy. SIADH is not rare in patients with NMO/NMOSD, especially in patients with lesions close to the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315741     DOI: 10.1007/s00415-014-7537-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange.

Authors:  Shohei Watanabe; Ichiro Nakashima; Isabelle Miyazawa; Tatsuro Misu; Yusei Shiga; Yoichi Nakagawa; Kazuo Fujihara; Yasuto Itoyama
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

2.  Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.

Authors:  Toru Baba; Ichiro Nakashima; Takashi Kanbayashi; Masatoshi Konno; Toshiyuki Takahashi; Kazuo Fujihara; Tatsuro Misu; Atsushi Takeda; Yusei Shiga; Hiromasa Ogawa; Yasuto Itoyama
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

3.  Aquaporin-4 antibody positive neuromyelitis optica with syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Xiao-Fan You; Wei Qin; Wen-Li Hu
Journal:  Neurosciences (Riyadh)       Date:  2011-01       Impact factor: 0.906

4.  Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica.

Authors:  Youming Long; Wei Qiu; Zhengqi Lu; Jian Bao; Aimin Wu; Yuge Wang; Honghao Wang; Xueqiang Hu
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

5.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

6.  [Neuromyelitis optica with syndrome of inappropriate secretion of antidiuretic hormone and hypersomnia associated with bilateral hypothalamic lesions: a case report].

Authors:  Takeshi Nakano; Takeshi Fujimoto; Yasuo Fukuda; Toshiyuki Takahashi; Takashi Kanbayashi
Journal:  Rinsho Shinkeigaku       Date:  2011-08

7.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

8.  Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in a patient with multiple sclerosis.

Authors:  E Ishikawa; S Ohgo; K Nakatsuru; Y Yamamura; M Nagamine; T Kuribayashi; S Matsukura
Journal:  Jpn J Med       Date:  1989 Jan-Feb

9.  Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations.

Authors:  T Takahashi; I Miyazawa; T Misu; R Takano; I Nakashima; K Fujihara; M Tobita; Y Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-17       Impact factor: 10.154

10.  Spectrum of pediatric neuromyelitis optica.

Authors:  Timothy E Lotze; Jennifer L Northrop; George J Hutton; Benjamin Ross; Jade S Schiffman; Jill V Hunter
Journal:  Pediatrics       Date:  2008-10-06       Impact factor: 7.124

View more
  7 in total

1.  Neuromyelitis optica spectrum disorder associated with osmotic demyelination syndrome.

Authors:  Ivan Adamec; Filip Keršić; Luka Crnošija; Mario Habek
Journal:  Neurol Sci       Date:  2016-01-28       Impact factor: 3.307

Review 2.  Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Authors:  Jayne L Chamberlain; Saif Huda; Daniel H Whittam; Marcelo Matiello; B Paul Morgan; Anu Jacob
Journal:  J Neurol       Date:  2019-09-03       Impact factor: 4.849

Review 3.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

4.  Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Chia Lun Hsu; Jiann Horng Yeh; Chi Ieong Lau
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

5.  Hyponatremia Associated with Prophylactic Low-Dose Trimethoprim during Systemic Corticosteroid Therapy for AQP4-Positive Optic Neuritis in a Diabetic Patient.

Authors:  Masahiro Takubo; Sho Tanaka; Masaru Kushimoto; Jin Ikeda; Katsuhiko Ogawa; Yutaka Suzuki; Masanori Abe; Hisamitsu Ishihara; Midori Fujishiro
Journal:  Antibiotics (Basel)       Date:  2020-04-23

6.  Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan.

Authors:  Toshiyuki Hayashi; Shunya Nakane; Akihiro Mukaino; Osamu Higuchi; Makoto Yamakawa; Hidenori Matsuo; Kazumi Kimura
Journal:  Ther Adv Neurol Disord       Date:  2022-08-03       Impact factor: 6.430

Review 7.  AQP4-IgG positive paraneoplastic NMOSD: A case report and review.

Authors:  Manqiu Ding; Yue Lang; Li Cui
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.